Alan Schafer

Jul 14, 2015

14M Genomics appointed Alan Schafer its CEO. He was previously CEO of Population Genetics Technologies, and before that he was the director of science funding at Wellcome Trust. Prior to that, Schafer was global vice president of technology development at GlaxoSmithKline, and was a co-founder of Hexagen.